All Type of News
70% of diabetes patients delays treatment due to fear of injection needle
It is surveyed that almost 70.3% of diabetes patients have suitable treatment moments by resistance to injections despite recommendations of doctors. It is observed that it takes averagely 5.9 months for the patients ...
The NOAC benefit expanssion has heated competition of the anti-coagulant market
By the benefit expansion of the new oral anti-coagulant(NOAC), competition in the NOAC market is expected to be serious.
As the Ministry of Health and Welfare revised and issued the benefit expansion to the primary d...
The total amount of assets of listed pharmaceutical companies increased 6.4% up in the 1st quarter of the year
It is observed that the total amount of assets(capital + liability) of listed Korean pharmaceutical companies in the 1st quarter of the year increased 6.4% compared to the same quarter of the last year. Capitals and l...
The number of antibody prescriptions has constantly decreased while prescriptions for more than 6 products are increased by a small margin
It is known that antibody prescriptions have been continuously decreased for acute upper respiratory infection, such as flu. However, the decreasing trend on the number of pharmaceutical products per description has b...
5083 benefited drugs decreased 2.1% in price, enforced on March next year
Since the Drug Price Adjustment System over Real Transaction Pharmaceutical Price will be applied, drug price of 5,000 listed pharmaceutical products is expected to be decreased by approximately 2%.
The Ministry of H...
GSK has acquired an approval for ‘Incruse Ellipta,’ reinforcing its COPD lineupGSK is in the heat of reinforcing its respiratory disease treatment pipeline. It is working on a long-acting anticholinergic(LAMA) drug this time.
The company has acquired a sa...
|
Chief Sang-bong Kim stated “Since the membership of the PIC/s, pharmaceutical competitiveness has been raised”
Last July, the Ministry of Food and Drug Safety became a member country of the Pharmaceutical Inspection Co-operation Scheme(PIC/s).
It was spoke by Division Chief Sang-bong Kim of the Pharmaceutical Quality Manageme...
The 36 1st innovation pharmaceutical companies are decided to be renewed with their certification
Among the 1st innovation pharmaceutical companies, certifications of only 36 companies have been decided to be renewed.
The Minister of Health and Welfare (Minister Hyung-pyo Moon) announced, on the 26th, the certifi...
Why are the 5 companies missing from the innovation pharmaceutical company list?
In regards to the recertification of the 1st innovation pharmaceutical companies, various suspicion has been poured out. While 36 companies, such as Green Cross, Chong Kun Dang, Samjin Pharm, Ahngook Pharm and Hanmi P...
A directly-damaged clinic by MERS received KRW 32.44 million damages on average
It is observed that the MERS crisis has caused KRW 12 million to KRW 32 million damages per local clinic.
According to the survey result conducted on the total 40 clinics, 20 indirect and 20 direct damages due to MER...
